Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    GSK Anti-IL5 MHE 104317 Mepolizumab
Show Display Options
Rank Status Study
1 Recruiting Compassionate Use of Mepolizumab in Subjects With Hypereosinophilic Syndrome (HES)
Condition: Hypereosinophilic Syndrome
Intervention: Drug: mepolizumab

Study has passed its completion date and status has not been verified in more than two years.